First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) is a publicly traded the market company. As of October 20, 2026, TRAX trades at $40.25 with a market cap of $1.30B and a P/E ratio of 0.00. TRAX moved +13.81% today. Year to date, TRAX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $14.72 to $49.91. Analyst consensus is strong buy with an average price target of $74.20. Rallies surfaces TRAX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for TRAX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $40.25 |
| Market Cap | $1.30B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $49.91 |
| 52-Week Low | $14.72 |
| Volume | 905.22K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
11 analysts cover TRAX: 0 strong buy, 11 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $74.20.